Wird geladen...
Chimeric antigen receptor T-cell therapy in AML: How close are we?
The majority of patients presenting with acute myeloid leukemia (AML) initially respond to chemotherapy but post-remission therapy is required to consolidate this response and achieve long-term disease-free survival. The most effective form of post-remission therapy relies on T-cell immunotherapy in...
Gespeichert in:
| Veröffentlicht in: | Best Pract Res Clin Haematol |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5131522/ https://ncbi.nlm.nih.gov/pubmed/27890255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2016.10.004 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|